Bavarian Nordic A-S is a fully integrated vaccine company dedicated to the development, manufacturing, and commercialization of life-saving vaccines. Founded in 1994, the company has over 30 years of experience and is recognized as a global leader in smallpox and mpox vaccines. With a diverse portfolio that includes vaccines for rabies, tick-borne encephalitis, cholera, typhoid, and Ebola, Bavarian Nordic operates from its headquarters in Denmark, with additional manufacturing, research, and sales offices across Europe and North America. The company is committed to protecting lives every day and fosters a culture of innovation, teamwork, and professional development among its more than 1,600 employees. Bavarian Nordic values inclusivity and is an Equal Opportunity Employer, ensuring a diverse and supportive workplace.